Growth Metrics

Cue Biopharma (CUE) Amortizatization of Intangibles (2020 - 2025)

Cue Biopharma (CUE) has disclosed Amortizatization of Intangibles for 5 consecutive years, with -$30000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles changed N/A to -$30000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$212000.0 for FY2025, N/A changed from the prior year.
  • Amortizatization of Intangibles hit -$30000.0 in Q4 2025 for Cue Biopharma, down from -$12000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $3.0 million in Q4 2021 to a low of -$220000.0 in Q4 2022.
  • Historically, Amortizatization of Intangibles has averaged $306330.9 across 4 years, with a median of -$51500.0 in 2023.
  • Biggest five-year swings in Amortizatization of Intangibles: soared 45323.47% in 2021 and later crashed 107.24% in 2022.
  • Year by year, Amortizatization of Intangibles stood at $3.0 million in 2021, then plummeted by 107.24% to -$220000.0 in 2022, then skyrocketed by 94.55% to -$12000.0 in 2023, then tumbled by 150.0% to -$30000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for CUE at -$30000.0 in Q4 2025, -$12000.0 in Q3 2023, and -$73000.0 in Q2 2023.